prof. dr. H.J. (Hiddo) Lambers Heerspink

Clinical Pharmacologist

Faculty of Medical Sciences

Telephone:

+31 50 361 7859

E-mail:

h.j.lambers.heerspink umcg.nl

ORCID Research Portal

Publications

Albuminuria Responses to Dapagliflozin in Patients With Type 2 Diabetes: A Crossover Trial

Beernink, J., Jongs, N., Doelman, C., Laverman, G. & Heerspink, H., 24-Mar-2025, In: Jama network open. 8, 3, 11 p., e251689.

Research output: Contribution to journal › Article › Academic › peer-review

Authors' Reply: Effects of Zibotentan and Dapagliflozin on Fluid Retention in Patients with CKD: Need More Evidence

Heerspink, H. J. L. & Smeijer, J. D., Feb-2025, In: Journal of the American Society of Nephrology. 36, 2, p. 324 1 p.

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

Authors’ Reply: Unlocking the Potential of SC0062: A New Horizon in IgA Nephropathy Treatment?

Chen, J. & Heerspink, H. J. L., Apr-2025, In: Journal of the American Society of Nephrology. 36, 4, p. 746 1 p.

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

Canagliflozin and iron metabolism in the CREDENCE trial

Koshino, A., Heerspink, H. J. L., Jongs, N., Badve, S. V., Arnott, C., Neal, B., Jardine, M., Mahaffey, K. W., Pollock, C., Perkovic, V., Hansen, M. K., Bakker, S. J. L., Wada, T. & Neuen, B. L., 1-Apr-2025, In: Nephrology Dialysis Transplantation. 40, 4, p. 696-706 11 p.

Research output: Contribution to journal › Article › Academic › peer-review

Canagliflozin reduces oral loop diuretic intensification in patients with type 2 diabetes: A participant-level pooled analysis of the CANVAS and CREDENCE trials

Chatur, S., Vaduganathan, M., Fletcher, R. A., Perkovic, V., Heerspink, H., Arnott, C., Pollock, C., Mahaffey, K. W., Neal, B., Jardine, M., Solomon, S. D. & Neuen, B. L., 23-Jan-2025, (E-pub ahead of print) In: European Journal of Heart Failure. 27, 6, p. 994-1002 9 p.

Research output: Contribution to journal › Article › Academic › peer-review

Cardiovascular, kidney and safety outcomes with canagliflozin in older adults: A combined analysis from the CANVAS Program and CREDENCE trial

Siriwardana, A., Buizen, L., Jun, M., Kotwal, S., Arnott, C., Jardine, M. J., Levin, A., Heerspink, H. J. L., Charytan, D. M., Pollock, C., Perkovic, V. & Neuen, B. L., Apr-2025, In: Diabetes, Obesity and Metabolism. 27, 4, p. 1972-1979 8 p.

Research output: Contribution to journal › Article › Academic › peer-review

Comparison of radioactive and non-radioactive iothalamate and hippuran to assess kidney function

Mohamed, A. A. A., Gansevoort, R. T., van de Merbel, N. C., van Londen, M., de Borst, M. H., Zijlma, R., Junier, L. A. T., Heerspink, H. J. L. & Stevens, J., 23-Sept-2025, (Accepted/In press) In: Clinical Kidney Journal. 21 p., sfaf293.

Research output: Contribution to journal › Article › Academic › peer-review

Compositions and methods for treating and preventing kidney disease

Kretzler, M. (Inventor), Bjornstad, P. (Inventor), Ju, W. (Inventor), Nair, V. (Inventor) & Heerspink, H. (Inventor), 30-Jan-2025, Patent No. WO2025024212, 18-Jul-2024, Priority date 26-Jul-2023

Research output: Patent

Contribution of the glomerular filtration rate slope to the kidney hierarchical composite endpoint

Little, D. J., Jongs, N., Brinker, M., Gasparyan, S. B., Schloemer, P. & Heerspink, H. J. L., Jun-2025, In: Kidney International. 107, 6, p. 1104-1107 4 p.

Research output: Contribution to journal › Article › Academic › peer-review

Corrigendum to “Study Design and Baseline Characteristics of ALIGN, a Randomized Controlled Study of Atrasentan in Patients With IgA Nephropathy”

Heerspink, H. J. L., Jardine, M., Kohan, D. E., Lafayette, R. A., Levin, A., Liew, A., Zhang, H., Noronha, I., Trimarchi, H., Hou, F. F., Renfurm, R., Gray, T., Camargo, M. & Barratt, J., Apr-2025, In: Kidney International Reports. 10, 4, p. 1302 1 p.

Research output: Contribution to journal › Erratum